Lockheed Martin Investment Management’s Elevance Health ELV Stock Holding History

Lockheed Martin Investment Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-21,400	Closed	-$7.98M	–	174
2021 Q3	$7.98M	Buy	21,400 +3,610	+20%	+$1.37M	0.43%	46
2021 Q2	$6.79M	Sell	17,790 -5,310	-23%	-$2.03M	0.36%	62
2021 Q1	$8.29M	Sell	23,100 -1,650	-7%	-$531K	0.42%	58
2020 Q4	$7.95M	Buy	+24,750	New	+$7.6M	0.41%	54
2018 Q2	–	Sell	-3,400	Closed	-$747K	–	100
2018 Q1	$747K	Buy	+3,400	New	+$799K	0.03%	102
2017 Q3	–	Sell	-3,500	Closed	-$658K	–	138
2017 Q2	$658K	Buy	+3,500	New	+$629K	0.04%	123
2015 Q4	–	Sell	-54,000	Closed	-$7.56M	–	92
2015 Q3	$7.56M	Buy	54,000 +16,000	+42%	+$2.4M	0.85%	19
2015 Q2	$6.24M	Hold	38,000	–	–	0.31%	39
2015 Q1	$5.87M	Buy	38,000 +3,100	+9%	+$441K	0.28%	42
2014 Q4	$4.39M	Buy	34,900 +7,900	+29%	+$976K	0.19%	39
2014 Q3	$3.23M	Buy	+27,000	New	+$3.1M	0.15%	58

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Lockheed Martin Investment Management's ELV Position: Q4 2021 in Review

Lockheed Martin Investment Management sold out of Elevance Health (ELV) in Q4 2021, closing a stake of 21,400 shares — an estimated $7.98M sold.

Lockheed Martin Investment Management first reported a position in ELV in Q3 2014 and held it in 11 quarters. The position peaked at $8.29M in Q1 2021. 1,373 funds tracked by Wall St. Rank hold ELV as of Q4 2021.

Lockheed Martin Investment Management reported no remaining Elevance Health position as of Q4 2021 after selling out during the quarter.
Lockheed Martin Investment Management sold 21,400 Elevance Health shares in Q4 2021, an estimated $7.98M.
Lockheed Martin Investment Management first reported a position in Elevance Health in Q3 2014 and held it in 11 quarters.
Lockheed Martin Investment Management's Elevance Health position peaked at $8.29M in Q1 2021.
1,373 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.

Based on Lockheed Martin Investment Management's 13F filing for Q4 2021, filed 10 Feb 2022.